ライフサイエンスコーパス: positive airway pressure

1 pressure control system (5 cm H2O continuous positive airway pressure).

2 or patients who are intolerant to continuous positive airway pressure.

3 early introduction of less invasive forms of positive airway pressure.

4 he first line of therapy is nasal continuous positive airway pressure.

5 t were superimposed on a baseline continuous positive airway pressure.

6 usion of lungs held motionless by continuous positive airway pressure.

7 assisted spontaneous breathing, and biphasic positive airway pressure.

8 to 0.40 and received 5 cm H2O of continuous positive airway pressure.

9 ith supplemental oxygen and nasal continuous positive airway pressure.

10 -by methods in patients receiving continuous positive airway pressure.

11 ither non-invasive ventilation or continuous positive airway pressure.

12 increase in the duration of nasal continuous positive airway pressure.

13 ) during spontaneous breathing or continuous positive airway pressure.

14 ith a GA less than 34 weeks under continuous positive airway pressure.

15 ratory pressure support on top of expiratory positive airway pressure.

16 in the first hours of life under continuous positive airway pressure.

17 pressure support ventilation and continuous positive airway pressure (0.46+/-0.11 L and 0.44+/-0.11

18 7 x 10(2) PFU/L of air sampled), and bilevel positive airway pressure (1.91 x 10(2) PFU/L of air samp

19 ect of increased airway pressure (continuous positive airway pressure, 20 cm H2O; n = 12) and simulat

20 nimals underwent lung recruitment continuous positive airway pressure 40 cm H2O for 40 secs to normal

21 preextubation trial (FIO2 = 0.21, continuous positive airway pressure = 5 cm H2O [0.5 kPa]).

22 dolescents, a group that has poor continuous positive airway pressure adherence and difficulty in ach

23 Compared with biphasic positive airway pressure/airway pressure release ventila

24 pressure release ventilation of 0%, biphasic positive airway pressure/airway pressure release ventila

25 Biphasic positive airway pressure/airway pressure release ventila

26 lammation, and damage compared with biphasic positive airway pressure/airway pressure release ventila

27 piratory distress syndrome in pigs, biphasic positive airway pressure/airway pressure release ventila

28 Biphasic positive airway pressure/airway pressure release ventila

29 on (n = 9 per group, 6 hr each): 1) biphasic positive airway pressure/airway pressure release ventila

30 ressure release ventilation, 0%; 2) biphasic positive airway pressure/airway pressure release ventila

31 re release ventilation, > 0-30%; 3) biphasic positive airway pressure/airway pressure release ventila

32 lease ventilation, > 30-60%, and 4) biphasic positive airway pressure/airway pressure release ventila

33 etter pulmonary outcomes than the continuous positive airway pressure alone group.

34 ubation method (200 mg/kg), or 3) continuous positive airway pressure alone.

35 is: 115 were allocated to receive continuous positive airway pressure and 118 to receive standard car

36 Delivery of pressure-stable continuous positive airway pressure and avoiding face mask use coul

37 The old modes of continuous positive airway pressure and bilevel positive airway pre

38 Studies show that continuous positive airway pressure and non-invasive positive press

39 mmarize the current management of continuous positive airway pressure and noninvasive positive pressu

40 to surgical treatment, the use of continuous positive airway pressure and noninvasive positive pressu

41 use of NRS including preinduction continuous positive airway pressure and postextubation NRS for high

42 pulmonary artery pressure in both continuous positive airway pressure and pressure control groups imm

43 L, Total Face) were tested during continuous positive airway pressure and pressure support ventilatio

44 hild Health and Human Development Surfactant Positive Airway Pressure and Pulse Oximetry Randomized T

45 tube placement with delivery room continuous positive airway pressure and use of less invasive surfac

46 itive pressure ventilation (i.e., continuous positive airway pressure and/or intubation).

47 ntained at a therapeutic level of continuous positive airway pressure, and nasal pressure was acutely

48 on for ventilation treatment with continuous positive airway pressure, and other potential ocular and

49 al lung aeration within 48 hrs of continuous positive airway pressure applied via the endobronchial b

50 Interventions such as positive airway pressure are recommended for those with

51 Subjects were ventilated with continuous positive airway pressure at 5 cm H2O, spontaneous ventil

52 re techniques such as continuous and bilevel positive airway pressure avoid intubation and its attend

53 Bubble continuous positive airway pressure (bCPAP) is a low-cost, non-inva

54 Non-invasive bubble continuous positive airway pressure (bCPAP) is considered a safe ve

55 Continuous positive airway pressure benefits in high-risk OSA were

56 Noninvasive ventilation delivered as bilevel positive airway pressure (BiPAP) is often used to avoid

57 ing intubation for patients failing Bi-Level Positive Airway Pressure (BIPAP) may be associated with

58 n is more complex and costly than continuous positive airway pressure but might be advantageous becau

59 in delivering prolonged treatments with high positive airway pressure, but data about its effectivene

60 iews indicated that delivery room continuous positive airway pressure compared with intubation with o

61 12.8; p<0.0001) after 3 months of continuous positive airway pressure, compared with standard care al

62 9.6; p<0.0001) after 3 months of continuous positive airway pressure, compared with standard care al

63 n: (1) patients with OSAS without continuous positive airway pressure (CPAP) (n = 13); (2) patients w

64 +/- 0.3 cmH(2)O l(-1) s; optimal continuous positive airway pressure (CPAP) = 11.3 +/- 0.7 cmH(2)O)

65 mine how long-term treatment with continuous positive airway pressure (CPAP) affects cardiac autonomi

66 Continuous positive airway pressure (CPAP) and high-flow nasal oxyg

67 Continuous positive airway pressure (CPAP) and mandibular advanceme

68 dence for and the clinical use of continuous positive airway pressure (CPAP) and positive end-expirat

69 Data regarding the use of continuous positive airway pressure (CPAP) and recurrence of AF wer

70 28 weeks who were supported with continuous positive airway pressure (CPAP) and required a fraction

71 repositioning splints (MRSs) and continuous positive airway pressure (CPAP) are used to treat the sl

72 herapy is an alternative to nasal continuous positive airway pressure (CPAP) as a means of respirator

73 Although continuous positive airway pressure (CPAP) can mitigate these risks

74 Meta-analysis found that continuous positive airway pressure (CPAP) compared with sham was s

75 ea Symptoms Questionnaire (SASQ), continuous positive airway pressure (CPAP) compliance, and physicia

76 rapeutic and economic benefits of continuous positive airway pressure (CPAP) for moderate to severe o

77 ngly popular alternative to nasal continuous positive airway pressure (CPAP) for noninvasive respirat

78 nclear whether OSA treatment with continuous positive airway pressure (CPAP) has metabolic benefits.

79 xygen therapy delivered by bubble continuous positive airway pressure (CPAP) improved outcomes compar

80 tent evidence that treatment with continuous positive airway pressure (CPAP) improves cardiovascular

81 Continuous positive airway pressure (CPAP) in asthma patients with

82 noninvasive ventilation (NIV) or continuous positive airway pressure (CPAP) in the early postoperati

83 Continuous positive airway pressure (CPAP) is considered the treatm

84 ulmonary resuscitation (CPR), but continuous positive airway pressure (CPAP) is increasingly discusse

85 Continuous positive airway pressure (CPAP) is the first-line and cr

86 Continuous positive airway pressure (CPAP) is the first-line treatm

87 Continuous positive airway pressure (CPAP) is the most common treat

88 Nasal continuous positive airway pressure (CPAP) is the treatment of choi

89 Continuous positive airway pressure (CPAP) is the treatment of choi

90 Although continuous positive airway pressure (CPAP) is used frequently for p

91 Continuous positive airway pressure (CPAP) is used to minimize airw

92 le 3-min 'drops' from therapeutic continuous positive airway pressure (CPAP) levels.

93 py in patients who cannot tolerate continous positive airway pressure (CPAP) machines or intraoral de

94 physiology study performed using continuous positive airway pressure (CPAP) manipulations indicated

95 Adherence to short-term continuous positive airway pressure (CPAP) may predict long-term us

96 sought to determine the effect of continuous positive airway pressure (CPAP) of patients with OSA on

97 noninvasive ventilation (NIV) or continuous positive airway pressure (CPAP) on cardiac structure and

98 ttle evidence about the effect of continuous positive airway pressure (CPAP) on glycemic control in p

99 termine the short-term effects of continuous positive airway pressure (CPAP) on sleep-disordered brea

100 r study of the effects of 4 wk of continuous positive airway pressure (CPAP) or oral placebo on 24-h

101 yndrome in premature infants with continuous positive airway pressure (CPAP) preserves surfactant and

102 ositive airway pressure (PAP), 3) continuous positive airway pressure (CPAP) rather than noninvasive

103 Continuous positive airway pressure (CPAP) reduces blood pressure,

104 ce of lung volume on the level of continuous positive airway pressure (CPAP) required to prevent flow

105 Continuous positive airway pressure (CPAP) therapy is the most comm

106 tudy was to examine the effect of continuous positive airway pressure (CPAP) therapy on atrial fibril

107 The effects of continuous positive airway pressure (CPAP) therapy on endothelial f

108 nce of spontaneous breathing with continuous positive airway pressure (CPAP) therapy on the relative

109 Short-term studies indicate that continuous positive airway pressure (CPAP) therapy reduces blood pr

110 hese patients had been prescribed continuous positive airway pressure (CPAP) therapy to manage OSA an

111 Prolonged continuous positive airway pressure (CPAP) therapy with supplementa

112 ested after at least two weeks of continuous positive airway pressure (CPAP) therapy.

113 after compliance-monitored nasal continuous positive airway pressure (CPAP) therapy.

114 e inspiratory flow contour during continuous positive airway pressure (CPAP) titration in obstructive

115 ce (V D) and can be combined with continuous positive airway pressure (CPAP) to decrease minute volum

116 y, endothelium, inflammation, and continuous positive airway pressure (CPAP) to identify peer-reviewe

117 kefulness with the application of continuous positive airway pressure (CPAP) to the upper airway.

118 ), the blood pressure response to continuous positive airway pressure (CPAP) treatment is highly vari

119 ttle evidence about the effect of continuous positive airway pressure (CPAP) treatment on blood press

120 btherapeutic (0-1 cm H(2)O) nasal continuous positive airway pressure (CPAP) treatment on polysomnogr

121 e (CHD) in women, and the role of continuous positive airway pressure (CPAP) treatment on this associ

122 ized therapeutic decision-making, continuous positive airway pressure (CPAP) treatment or a healthy h

123 ted the hypothesis that long-term continuous positive airway pressure (CPAP) treatment will decrease

124 s with OSA who were intolerant to continuous positive airway pressure (CPAP) treatment, submitted to

125 sensory evaluation in response to continuous positive airway pressure (CPAP) treatment.

126 We tested the hypothesis that continuous positive airway pressure (CPAP) use and outcomes can be

127 noninvasive ventilation (NIV) and continuous positive airway pressure (CPAP) use in patients with OHS

128 in blood pressure associated with continuous positive airway pressure (CPAP) use, with smaller or unc

129 our trial of early treatment with continuous positive airway pressure (CPAP) versus early surfactant

130 ng basal breathing (BB) and nasal continuous positive airway pressure (CPAP) was applied to reduce ne

131 ecrement in muscle activity nasal continuous positive airway pressure (CPAP) was applied to reduce ne

132 efficacy similar to that of nasal continuous positive airway pressure (CPAP) when used as postextubat

133 We delivered continuous positive airway pressure (CPAP) with the helmet under a

134 s air (sham) on morning BP, after continuous positive airway pressure (CPAP) withdrawal in patients w

135 We aimed to determine if continuous positive airway pressure (CPAP), a form of non-invasive

136 r liter to receive treatment with continuous positive airway pressure (CPAP), a weight-loss intervent

137 treatment for symptomatic OSA is continuous positive airway pressure (CPAP), but its value in patien

138 fter 60 d of treatment with nasal continuous positive airway pressure (CPAP), E(max) to bradykinin ro

139 Current treatments, such as continuous positive airway pressure (CPAP), have shown limited cogn

140 (AC), pressure support (PS), and continuous positive airway pressure (CPAP), separately with a dry a

141 liminated by application of nasal continuous positive airway pressure (CPAP), SPC-muscle activity was

142 SA who received a prescription of continuous positive airway pressure (CPAP), were 40 to 89 years of

143 in SNA through the application of continuous positive airway pressure (CPAP), which remains a primary

144 ssure ventilation (IPPV) or nasal continuous positive airway pressure (CPAP)--at the time of the firs

145 arison to the standard therapy of continuous positive airway pressure (CPAP).

146 re well treated and adherent with continuous positive airway pressure (CPAP).

147 d only for their SDB, using nasal continuous positive airway pressure (CPAP).

148 p and during application of nasal continuous positive airway pressure (CPAP).

149 Noninvasive ventilation (continuous positive airway pressure [CPAP] or noninvasive intermitt

150 pronged approach of delivery room continuous positive airway pressure, early selective surfactant adm

151 ewborn piglets to investigate the continuous positive airway pressure failure rate with nebulized por

152 fterward, patients were placed on continuous positive airway pressure for 1-2 mins to measure their s

153 0 cm H2O for 2 hours (phase 2) or continuous positive airway pressure for 2 hours (phase 3), and then

154 t effective treatment of OSA with continuous positive airway pressure for 3 months significantly redu

155 airway pressure of 30 cm H2O: 1) continuous positive airway pressure for 30 seconds (CPAP-30); 2) st

156 recruitment maneuvers: 40 cm H2O continuous positive airway pressure for 60 secs and 40 cm H2O posit

157 ed as an alternative treatment to continuous positive airway pressure for patients with obstructive s

158 g whether to continue treatment for SDB with positive airway pressure given concern for aerosolizatio

159 al infarction rate was higher in the bilevel positive airway pressure group (71%) compared with both

160 t-year were 1.63 (SD 3.74) in the continuous positive airway pressure group and 1.44 (3.07) in the no

161 At 30 mins; the bilevel positive airway pressure group had greater reductions in

162 in diastolic blood pressure occurred in the positive airway pressure group than in the usual care gr

163 ventilation group and 107 in the continuous positive airway pressure group were included in the anal

164 ts occurred (one allocated to the continuous positive airway pressure group) and all were unrelated t

165 ts, 5.37 years (4.36-6.32) in the continuous positive airway pressure group, and 5.55 years (4.53-6.5

166 7 +/- 1.2 kPa]) were observed in the bilevel positive airway pressure group, as were significant impr

167 ventilation group and 115 to the continuous positive airway pressure group, of which 97 patients in

168 Furthermore, unlike in the continuous positive airway pressure group, there were no cases of r

169 In both the control group and continuous positive airway pressure groups, Pao2 did not significan

170 ed in OSA patients who adhered to continuous positive airway pressure >/=4 hours daily.

171 gh-flow nasal cannula therapy and continuous positive airway pressure had similar efficacy (RR, 1.11;

172 Given that continuous positive airway pressure has lower complexity and cost,

173 ent to ventilation treatment with continuous positive airway pressure have an increased risk of secon

174 tinuous positive airway pressure and bilevel positive airway pressure have been actively introduced i

175 oea, non-invasive ventilation and continuous positive airway pressure have similar long-term effectiv

176 farctions associated with the use of bilevel positive airway pressure highlights the need for further

177 ized to the intervention received continuous positive airway pressure if breathing well or positive-p

178 Nasal continuous positive airway pressure immediately normalized the brea

179 3 months of treatment with continuous positive airway pressure improved the quality of life in

180 ns unclear whether treatment with continuous positive airway pressure improves daytime function in th

181 t of obstructive sleep apnea with continuous positive airway pressure improves not only patient-repor

182 Bilevel positive airway pressure improves ventilation and vital

183 t device, the main alternative to continuous positive airway pressure, improves endothelial function

184 function improved after starting continuous positive airway pressure in asthmatics with moderate to

185 Post hoc analysis of the ISAACC (Continuous Positive Airway Pressure in Patients with ACS and OSA) s

186 ted the clinical effectiveness of continuous positive airway pressure in patients with mild obstructi

187 nce to ventilation treatment with continuous positive airway pressure in patients with severe OSAS in

188 ssure ventilation was superior to continuous positive airway pressure in preventing extubation failur

189 Data as to the efficacy of continuous positive airway pressure in severe OSA have come from ra

190 ive ventilation (Venturi mask and continuous positive airway pressure) in the majority of cases.

191 nts were randomized to receive nasal bilevel positive airway pressure (inspiratory and expiratory pos

192 with mild to moderate OSA or for continuous positive airway pressure-intolerant patients.

193 Continuous positive airway pressure is a useful second-line treatme

194 Continuous positive airway pressure is generally first-line therapy

195 Continuous positive airway pressure is the treatment of choice, wit

196 Treatment with positive airway pressure lowers blood pressure, especial

197 sleep center; both plans included continuous positive airway pressure, mandibular advancement splints

198 OSA subjects were treated with continuous positive airway pressure (mean duration of 26 weeks), af

199 re has lower complexity and cost, continuous positive airway pressure might be the preferred first-li

200 g the ventilator while set in the continuous positive airway pressure mode were administered in rando

201 tion, patients were switched to the bi-level positive airway pressure mode with 1 second of 24 cm H2O

202 piratory cycles with supporting a continuous positive airway pressure model.

203 mized to auto-titrating CPAP (n = 122) or no positive airway pressure (n = 122).

204 ade 2, nasal cannula >2 L/min or noninvasive positive airway pressure (n = 617); and grade 3, invasiv

205 bstructive sleep apnea with nasal continuous positive airway pressure (nasal CPAP) will decrease auto

206 Nasal continuous positive airway pressure (NCPAP) is widely used as a tre

207 tory support noninferior to nasal continuous positive airway pressure (nCPAP) or bilevel nCPAP (BiPAP

208 m infants is optimal: noninvasive continuous positive airway pressure (NCPAP) or intubate-surfactant-

209 pressure can be reduced by nasal continuous positive airway pressure (nCPAP), such treatment could r

210 right (control) lung was kept on continuous positive airway pressure of 20 cm H2O, and CO2 was parti

211 home ventilator settings were an inspiratory positive airway pressure of 24 (IQR, 22-26) cm H2O, an e

212 ure of 24 (IQR, 22-26) cm H2O, an expiratory positive airway pressure of 4 (IQR, 4-5) cm H2O, and a b

213 on during airway occlusion and on continuous positive airway pressure of 5 and pressure support of 10

214 airway pressure (inspiratory and expiratory positive airway pressures of 15 and 5 cm H2O, respective

215 upported the beneficial effect of continuous positive airway pressure on quality of life, mood, and w

216 urfactant extubation technique or continuous positive airway pressure only.

217 Bi-level positive airway pressure or adaptive servo-ventilation c

218 in the first 72 hours (the use of continuous positive airway pressure or high-flow nasal cannula for

219 syndrome is commonly treated with continuous positive airway pressure or non-invasive ventilation dur

220 the major obstacle to successful continuous positive airway pressure or noninvasive positive pressur

221 During DCC, infants received continuous positive airway pressure or positive pressure ventilatio

222 Tidal volume during continuous positive airway pressure or pressure support ventilation

223 y use of high-flow nasal cannula, continuous positive airway pressure, or bilevel noninvasive ventila

224 that required a mask, continuous or bilevel positive airway pressure, or mechanical ventilation were

225 treatments include weight loss and exercise, positive airway pressure, oral appliances that hold the

226 ll participants were treated with continuous positive airway pressure over the 3-week period.

227 Background: Positive airway pressure (PAP) is a highly effective tre

228 cludes weight loss (if obese), exercise, and positive airway pressure (PAP) therapy.

229 stable ambulatory patients with OHS receive positive airway pressure (PAP), 3) continuous positive a

230 pnea symptoms, adherence to using continuous positive airway pressure, patient satisfaction, and heal

231 upport ventilation as a 35 cm H2O continuous positive airway pressure period lasting 3-4 seconds at d

232 igned (1:1) to either 3 months of continuous positive airway pressure plus standard care (sleep couns

233 t and underwent a 20-min room air-continuous positive airway pressure preextubation trial (FIO2 = 0.2

234 Continuous positive airway pressure preferentially improves cardiov

235 classes: spontaneous breathing or continuous positive airway pressure; pressure support ventilation 5

236 Although regulated continuous positive airway pressure, pulse oximeters, and blenders

237 iac output immediately after some continuous positive airway pressure recruitment maneuvers and a sig

238 ry, deep breathing exercises, and continuous positive airway pressure) reduce pulmonary risk.

239 Continuous positive airway pressure reduced extubation failure in c

240 In conclusion, NPPV with bilevel positive airway pressure reduces the rate of ETI in pati

241 Continuous positive airway pressure should be offered to patients w

242 ailure during a room air-5 cm H2O continuous positive airway pressure, spontaneous breathing, preextu

243 Bilevel positive airway pressure support ventilation failure was

244 The efficacy of bilevel positive airway pressure support ventilation in selected

245 Bilevel positive airway pressure support ventilation.

246 entilatory support were treated with bilevel positive airway pressure support ventilation.

247 ssure triggering of a demand-flow continuous positive airway pressure system creates an effect simila

248 er of ventilation measured during continuous positive airway pressure, T piece, or pressure support v

249 ward more aggressive use of nasal continuous positive airway pressure, the optimal timing of exogenou

250 Continuous positive airway pressure, the treatment of choice for ob

251 as significant in those who were adherent to positive airway pressure therapy (-4.4 mm Hg vs. -1.6 mm

252 s, who were previously prescribed continuous positive airway pressure therapy (CPAP) but were dissati

253 asingly popular and effective alternative to positive airway pressure therapy for patients with obstr

254 a significant reduction in sleepiness in the positive airway pressure therapy group (P < 0.0001).

255 , and mental component summary scores in the positive airway pressure therapy group.

256 performed at baseline and after 3 months of positive airway pressure therapy in a heterogeneous grou

257 Although continuous positive airway pressure therapy in patients with OSA mi

258 ed by initiation of autotitrating continuous positive airway pressure therapy in the home has greatly

259 Positive airway pressure therapy is frequently used to t

260 This trial showed no effect of positive airway pressure therapy on glycemic control in

261 ation index of 15 or more events per hour to positive airway pressure therapy or to usual care.

262 In OSA patients, continuous positive airway pressure therapy resulted in reduction o

263 However, it is not known whether positive airway pressure therapy results in improvements

264 Positive airway pressure therapy was associated with sig

265 We hypothesized that positive airway pressure therapy would be associated wit

266 ioral function in children after 3 months of positive airway pressure therapy, even in developmentall

267 After 4 weeks of continuous positive airway pressure therapy, flow-mediated dilation

268 me who are regular users of nasal continuous positive airway pressure therapy.

269 ness despite regular use of nasal continuous positive airway pressure therapy.

270 nother patient required noninvasive biphasic positive airway pressure throughout his course.

271 r treatment of confirmed OSA with continuous positive airway pressure to reduce driving risk, rather

272 stimulant medications or empiric continuous positive airway pressure to reduce driving risk.

273 e measured by repeatedly lowering continuous positive airway pressure to subtherapeutic levels for 3

274 lung isolation and application of continuous positive airway pressure to the left lung for 48 hrs.

275 -aged men and women (n = 82) with continuous positive airway pressure-treated obstructive sleep apnoe

276 RECOMMENDATION 2: ACP recommends continuous positive airway pressure treatment as initial therapy fo

277 kefulness should be combined with continuous positive airway pressure treatment during sleep.

278 ices as an alternative therapy to continuous positive airway pressure treatment for patients diagnose

279 Continuous positive airway pressure treatment improves the function

280 y pressure might be the preferred first-line positive airway pressure treatment modality until more s

281 Continuous positive airway pressure treatment was associated with r

282 Patients who received continuous positive airway pressure treatment were significantly le

283 -year incidences of both OSA (AHI of >/=5 or positive airway pressure treatment) and OSA concomitant

284 h adverse effects associated with continuous positive airway pressure treatment.

285 ized to 8 weeks of active or sham continuous positive airway pressure treatment.

286 am arm received 8 weeks of active continuous positive airway pressure treatment.

287 nd in the morning after effective continuous positive airway pressure treatment.

288 obstructive sleep apnea refusing continuous positive airway pressure treatment.Methods: In an intern

289 potential for behavioral, pharmacologic, and positive airway pressure treatments targeting sleep defi

290 e for high-flow nasal cannula and continuous positive airway pressure use in a monitored setting to p

291 rm) and OSA management (ie, none, continuous positive airway pressure, uvulopalatopharyngoplasty, or

292 syndrome were randomized to three continuous positive airway pressure-ventilated groups: 1) nebulized

293 We tested whether a continuous positive airway pressure ventilation strategy mitigates

294 ess the effects of treatment with continuous positive airway pressure versus conservative therapy (CT

295 for randomized clinical trials of continuous positive airway pressure versus mechanical ventilation.

296 Compared with inactive control, positive airway pressure was associated with a significa

297 d for narcolepsy and hypersomnia; continuous positive airway pressure, weight loss, surgery, and oral

298 Nasal continuous positive airway pressure when OSAS was diagnosed.

299 e-pressure ventilation (NPPV), using bilevel positive airway pressure, with usual medical care (UMC)

300 ugh most infants were ventilated, continuous positive airway pressure without ventilation increased f